1Roland ME, Martin JN, Grant RM, et al. Postexposure prophylixis for human immunodeficiency ivrus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure[ J ]. J Infect Dis, 2001,184 (12): 1608 -
2Almeda J, Casabona J ,Allepuz A,et al. Recommendations for non-occupational postexposure HIV prophylaxis. Spanish Working Group on Non-occupational Postexposure HIV prophylaxis of the Catalonian Center for Epidemiological Studies on AIDS and the AIDS Stud
3Wang SA, panlilio AL, Doi PA, et al. experience of healthcare workers talking postexposure prophylaxis after occupational HIV exposure:findings of the HIV Postexposure Prophylaxis Registry[J ]. Infect Control Hosp Epidemiol,2000,21:780- 785.
4Bottiger D,Johansson N-G,Samuelsson B,et al. Prevention of simian immunodeficiency wirus, SIVsm or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA- 005[ J ].AIDS, 1997,11:157 - 162.
5Martin LN,Murphey-corb M,Soike KF,et al. Effects of initiation of 3' -azido, 3' -deoxythymidine(zidovudine) treatment at different times after infection of rhesus monkeys iwth simian immunodeficiency virus [J]. J Infect Dis, 1993,168:825 - 835.
6Mori K, Yasutomi Y, Sawada S, et al. suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency wirus SHIV-RT-imfected monkeys with a novel reverse transcriptase inhibitor(GW420867)allows for development of potent
7Tsai C-C, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of
8Busch M,Lee LL,Satten GA,et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors [J]. Transfusion, 1995,35:91 - 97.
9Beltrami EM, Luo CC, de la Torre N, et al. Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen [ J ]. Infect Control Hosp Epidemiol,2002 Jun;23(6) :345 - 348.
10Deeks SG, Smith M, Holodniy M, et al. HIV-1 protease inhibitors: a reveiw for clinicans[ J ]. JAMA, 1997,277:145 - 153.
